Compliance & Accreditation · July 29, 2026 · Updated September 14, 2026
Blood Bank Record Retention: What to Keep and for How Long
For blood bank record retention, Schedule F Part XIIB section L requires a blood centre to preserve the records listed there for five years. Its note says, “The above records shall be preserved for a period of five years.” Section L does not say that the period runs from the date of the last entry. Rule 122G separately ties records of the required tests to the date of manufacture, while the widely repeated “two years from the date of the last entry” belongs to Rule 65(7) and must not be imported into the blood centre requirement.123
Five years is the period stated in Schedule F. If your centre retains a record for longer because of a licence condition, a written direction or its own policy, record that separate basis instead of attributing it to section L.
Retention and completeness are also different questions. Scanning a register preserves what somebody wrote on the page; it cannot create the donor, testing, component or issue entries that were never made. Both will be tested, and the second one usually fails first.
The Drugs and Cosmetics Act, 1940 is the parent legislation. The detailed blood centre record categories and retention conditions come from the Drugs and Cosmetics Rules, 1945, particularly Schedule F Part XIIB section L and Rule 122G.4
What Part XIIB requires you to keep
Part XIIB names the records by their particulars rather than by a form number, and a single note at the end of the list sets one period for all of them. If your retention schedule is organised around form numbers, check it against this list instead, because the Drugs and Cosmetics Rules, 1945 do not issue a prescribed record form for blood centre transactions.1
| Record Part XIIB names | Particulars it specifies |
|---|---|
| Blood donor record | Serial number, date of bleeding, donor name, address and signature, age, weight, haemoglobin, blood grouping, blood pressure, medical examination, bag number, the patient’s details where the donation is a replacement, whether the donation is voluntary or replacement, deferral records, and the signature of the medical officer in charge |
| Master record for blood and its components | Bag serial number, date of collection, date of expiry, quantity in millilitres, ABO and Rh group, results for HIV 1 and HIV 2 antibodies, malaria, VDRL, hepatitis B surface antigen and hepatitis C virus antibody, irregular antibodies where present, donor name and address, utilisation issue number, components prepared or discarded, and the signature of the medical officer in charge |
| Issue register | Serial number, date and time of issue, bag serial number, ABO and Rh group, total quantity in millilitres, recipient name and address, recipient group, unit or institution, cross-matching report details, and the indication for transfusion |
| Records of components supplied | Quantity supplied, compatibility report, recipient details, and the signature of the issuing person |
| Records of anticoagulant bags | For ACD, CPD, CPD-A and SAGM bags: manufacturer, batch number, date of supply, and testing results |
| Register of diagnostic kits and reagents used | Name of the kit or reagent, batch number, date of expiry, and date of use |
| Cross-matching report | The report the centre must issue to the patient together with the blood unit |
| Transfusion adverse reaction records | The reactions reported back to the centre |
| Purchase, use and stock records | Disposable needles, syringes and blood bags: what was bought, what was used, and what is in hand |
These are the records covered by the five-year note in section L.1 Read the list as one trail rather than nine filing cabinets. The bag serial number appears in the donor record, the master record and the issue register, which is what makes donor-to-recipient traceability testable at all.
Keep the worksheets, compatibility records and corrections that substantiate an entry with the record they belong to, for the same period. A register retained without them proves that something was written, not that it was right. Where a supporting worksheet is not separately named in section L, describe it in your retention index as support for the applicable listed record rather than presenting it as another statutory category.
What the five years runs from
Schedule F Part XIIB section L states the five-year period but names no starting event. Rule 122G answers a narrower question by specifying the date of manufacture for records of the tests required under that licence condition. Rule 65(7) contains a last-entry trigger, but it applies to the records governed by that rule and yields where the Rules provide otherwise.123
| Provision | Records covered | Period | Starting event stated in the text |
|---|---|---|---|
| Schedule F Part XIIB section L | The donor, master, issue, component, bag, kit, cross-match, reaction and stock records listed above | Five years | None stated |
| Rule 122G | Records of the tests required by the licence condition | Five years | Date of manufacture |
| Rule 65(7) | Registers and records governed by the conditions for licences to sell, stock or distribute drugs, except where otherwise provided | Not less than two years | Date of the last entry |
Do not convert the silence in section L into a final-entry calculation. For a bound register that stays open for years, the opening and closing dates remain useful archive metadata, but neither date becomes a Schedule F retention trigger merely because your centre recorded it.
Rule 122G also does not turn the date of manufacture into a general starting date for donor, issue, component and stock records. Its date condition belongs to the testing records identified by that rule.2 Part XIIB does not import the last-entry trigger found in Rule 65(7).
Keep the provisions separate in your retention schedule. Record the applicable instrument, the stated period and any starting event the instrument actually gives. Against section L, enter that the starting event is “not stated” rather than filling the gap with a centre-created statutory calculation.
Your centre may adopt a longer internal holding period, but the schedule should label that period as centre policy. If destruction depends on an interpretation of the unstated starting event, obtain and retain the written basis used for that decision. A line that says only “five years” cannot show whether the centre applied section L, the manufacture date required for testing records or another documented requirement.
That distinction matters when someone reviews a destruction entry. State the basis in your retention policy, apply it consistently, and do not present a cautious internal practice to an assessor as statutory wording. Where a licence condition or a state authority sets a longer period, the longer period governs.
Why the two-year rule does not apply to your centre
The phrase that causes most of the confusion is real. Rule 65(7) provides that, except where otherwise provided in the Rules, registers and records are to be preserved for not less than two years from the date of the last entry. Rule 65 sets the conditions of licences to sell, stock or distribute drugs, and its own words defer to any provision made elsewhere.3
A blood centre is provided for elsewhere. Part XIIB and the Rule 122G testing-record condition both set five years, so the two-year period never reaches your donor records, and the “last entry” trigger it carries does not travel with it. This matters practically in hospitals, where a pharmacy retention procedure written from Rule 65 sometimes becomes the template for the blood centre.
Two years and a last-entry calculation are correct for the pharmacy counter and wrong by three years for the blood centre next door. It belongs in the same category of avoidable finding as the rest of your Drugs and Cosmetics Rules compliance checklist.
What an assessor may ask you to retrieve
If an assessor selects one bag serial number, your centre should be able to move from the donor and collection entry to testing, component preparation, issue or final disposition without changing identifiers halfway through. The statutory list in Part XIIB tells you which record categories to retain; retrieving them as one connected file shows whether the trail is complete.1
| Starting point | Records to produce | Connection to check |
|---|---|---|
| Collected unit | Blood donor record, master record, anticoagulant bag record, and diagnostic kit or reagent entries | Bag serial number, collection details, grouping and test entries |
| Prepared component | Master record, component preparation records, and issue or documented final disposition | Parent unit, component details, expiry and utilisation |
| Issued unit | Issue register, cross-matching report, compatibility record, and records of components supplied where applicable | Bag serial number, recipient, issue time and cross-match details |
| Reported reaction | Transfusion adverse reaction record, issue entry, cross-matching report and master record | Recipient report back to the unit and its testing history |
| Consumable or bag batch | Purchase, use and stock records, anticoagulant bag records, or the diagnostic kit and reagent register | Manufacturer or batch, expiry, date of use and stock movement |
This retrieval view does not create a new statutory record or a new retention trigger. It brings together the entries Part XIIB already names. If the issue register opens immediately but the cross-matching report sits in an unnamed scan folder, your centre may have retained both documents and still be unable to produce a complete unit trail when asked.
Run the same check before approving destruction. Confirm that the proposed destruction date has a documented legal or policy basis and that an unsupported final-entry calculation has not been attributed to section L. Also check that removing one record will not break a connected record set that must still be available.
Why a scanned register may still be incomplete
A scan preserves the content visible on the page. Omitted fields stay omitted, missing attachments stay missing, and two separate registers still need a common identifier before anyone can show that their entries concern the same unit.
Before you treat a scanned archive as complete, pick one unit and check that the archive can produce:
- the donor and collection entry;
- the matching bag serial number;
- the grouping and test entries, with the kit and batch behind them;
- component preparation records, where components were made;
- the issue entry or the documented final disposition; and
- the history of any correction made to those records.
If one of those links exists only in a live spreadsheet or on paper outside the archive, what you have is a partial record trail with a complete-looking index. Poorly controlled software leaves the same gap by a different route, which the comparison of manual and digital blood bank management sets out.
A retention control that survives an inspection
Keep a retention index that records, for each record set, its name, the date range it covers, the statutory or licence basis, the retention period and any starting event actually stated by that instrument. Where section L gives no event, say so. You can still record where the file is stored, the date of its final entry, the proposed destruction date and who authorised any destruction, but the final-entry date is archive metadata rather than a Schedule F calculation.
Keep the index separate from the records themselves. Its purpose is to make an absence visible: without it, a missing box or an unrestored database export looks exactly like a record nobody has asked for yet. For testing records governed by Rule 122G, the index should retain the date-of-manufacture basis specified by that rule.2
Then test it the way an assessor will, by unit identifier rather than by register name. Ask someone other than the person who filed it to retrieve one unit end to end. Generate returns from these source records instead of maintaining a separate set of totals, which is also what keeps blood bank reporting defensible.
Whether the centre runs on paper or on a blood bank management system, the licensee remains responsible for records that are complete, legible and available for the required period. Software can preserve and retrieve what your team records; it cannot turn a missing entry or an unsupported retention calculation into a compliant record.
Sources
- Drugs and Cosmetics Rules, 1945, Schedule F, Part XII-B, section L, Central Drugs Standard Control Organisation cdsco.gov.in
- Drugs and Cosmetics Rules, 1945, Rule 122G, Central Drugs Standard Control Organisation cdsco.gov.in
- Drugs and Cosmetics Rules, 1945, Rule 65(7), Central Drugs Standard Control Organisation cdsco.gov.in
- Drugs and Cosmetics Act, 1940, India Code, Legislative Department, Ministry of Law and Justice indiacode.nic.in